Home GPCR & G Protein OX Receptor

OX Receptor

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR

Isoform-selective Products

Cat.No. Product Name Information Product Use Citations Product Validations
E4740 TAK-861 (Oveporexton) Oveporexton (TAK-861) is a potent, orally bioavailable agonist of orexin receptor 2 (OX2R), with an EC50 of 2.5 nM in calcium mobilization assays. It induces dose-dependent membrane depolarization in histaminergic neurons within the mouse tuberomammillary nucleus (TMN) with an EC50 of 31.7 nM.
S2160 Almorexant HCl Almorexant HCl (ACT-078573) is an orally active, dual orexin receptor antagonist with IC50 of 6.6 nM and 3.4 nM for OX1 and OX2 receptor, respectively. Phase 3.
J Adv Res, 2024, S2090-1232(24)00359-X
bioRxiv, 2024, 2024.07.06.602357
Cell Rep, 2022, 40(5):111153
Verified customer review of Almorexant HCl
S7585 SB-334867 SB-334867 is a selective orexin-1 (OX1) receptor antagonist.
J Pharmacol Exp Ther, 2025, 392(7):103624
J Neuroinflammation, 2020, 17(1):187
Med Sci Monit, 2019, 25:2886-2895
E0107 EMPA EMPA is a selective OX2 receptor antagonist and binds to human and rat OX2-HEK293 membranes with Kd values of 1.1 and 1.4 nM respectively.
Eur Heart J, 2024, 31:ehae472.
Oxid Med Cell Longev, 2022, 2022:1122494
S1545 SB408124 SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
Nat Chem Biol, 2017, 13(2):235-242
S6717 TCS-OX2-29 TCX-OX2-29 is a OX2R antagonist (pKi = 7.5) that exhibits >250-fold selectivity for hOX2R compared with hOX1R (IC50s = 40 nM and >10,000 nM, respectively).
J Pharmacol Exp Ther, 2025, 392(7):103624
S3503New Seltorexant Seltorexant (JNJ-42847922) is a potent and selective antagonist of the orexin-2 receptor (OX2R) exhibiting strong affinity (pKi ~8.0) for human OX2R. It promotes sleep onset and demonstrates antidepressant effects in major depressive disorder (MDD) patients with insomnia by blocking hyperarousal linked to depression and sleep disturbance.
S6726 MK1064 MK1064 is a selective orexin 2 receptor antagonist (2-SORA) with an IC50 of 18 nM.

Signaling Pathway Map